SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art

Abstract Identification of biomarkers in cancer immunotherapy that predict therapeutic response and/or limit adverse events are a critical need in the field. To address recent progress and hurdles around cancer biomarker development and utilization, the Society for Immunotherapy of Cancer (SITC) con...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, David R. Kaufman, Samir N. Khleif, Ena Wang, on behalf of the Society for Immunotherapy of Cancer Immuno-Oncology Biomarkers: State of the Art workshop speakers
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2018-12-01
Edice:Journal for ImmunoTherapy of Cancer
Témata:
Biomarkers
Cancer immunotherapy
PD-1/PD-L1
Checkpoint inhibitor
On-line přístup:http://link.springer.com/article/10.1186/s40425-018-0453-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky